-
Mashup Score: 3Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy - Journal of Clinical Immunology - 2 year(s) ago
Journal of Clinical Immunology –
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0JCI - The convalescent sera option for containing COVID-19 - 2 year(s) ago
To deploy convalescent serum administration for COVID-19 the following six conditions must be met: (i) availability of a population of donors who have recovered from the disease and can donate convalescent serum; (ii) blood banking facilities to process the serum donations; (iii) availability of assays, including serological assays, to detect SARS-CoV-2 in serum and virological assays to measure…
Source: www.jci.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
The convalescent sera option for containing COVID-19 [Mar 13, 2020] @ACasadevall1 & Pirofski @jclinicalinvest https://t.co/atbKqAqVbL #COVID19CP #COVID19 #2019nCoV #coronavirus https://t.co/iFk7hwqJSC
-
-
Mashup Score: 0
General Sessions Plenary Scientific Session Fundamental Science, Bleeding and Clotting, Anticoagulant Drugs, Translational Research, Non-Biological, Clinically Relevant, Thromboembolism, Diseases, SARS-CoV-2/COVID-19, Thrombotic Disorders, Infectious Diseases, Therapies, Biological Processes, Pathogenesis Jacob G Ludington, MD, PhD1,2*, Shabbir A…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
SARS-CoV-2 Ion Channel ORF3a Enables TMEM16F-Dependent Phosphatidylserine Externalization to Augment Procoagulant Activity of the Tenase and Prothrombinase Complexes [Sun, 12/12/21, 2-4p] Ludington et al. Abstract 1 #ASH21 Plenary https://t.co/p9l0b95iD0 #VTE #2019nCoV #COVID19
-
-
Mashup Score: 32
Original Article from The New England Journal of Medicine — Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Antibody Status & Incidence of SARS-CoV-2 Infection in Health Care Workers [Feb 11, 2021] @SheilaLumley et al. @NEJM https://t.co/DLbUTXuBAx #COVID19 n=12,541 HCW. + anti-spike or anti-nucleocapsid IgG Ab assoc w/ substantially reduced risk of #2019nCoV reinfection in 6 mon
-
-
Mashup Score: 9At-home COVID-19 testing for the omicron variant: 7 insights - 2 year(s) ago
Do at-home COVID-19 tests detect the omicron variant? What does a positive at-home COVID-19 test result mean? Chief Infection Control Officer Roy Chemaly, M.D., shares insights on testing for COVID-19 at home.
Source: MD Anderson Cancer CenterCategories: Hem/Oncs, Latest HeadlinesTweet-
At-home COVID-19 testing for the omicron variant: 7 insights [Jan 05, 2022] By Devon Carter @MDAndersonNews https://t.co/n330huoon9 #2019nCoV #COVID19 #Testing
-
-
Mashup Score: 2Fast coronavirus tests: what they can and can’t do - 2 year(s) ago
Rapid antigen tests are designed to tell in a few minutes whether someone is infectious. Will they be game changers?
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Fast coronavirus tests: what they can and can’t do: Rapid antigen tests are designed to tell in a few minutes whether someone is infectious. Will they be game changers? [Sep 16, 2020] @GiorgiaWithAnI @nature https://t.co/Of6L6m0zRy #2019nCoV #COVID19 #Testing #CCC19 https://t.co/kv4vFUeuar
-
-
Mashup Score: 4
Correspondence from The New England Journal of Medicine — Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated & Unvaccinated Persons [Dec 1, 2021] @StephenKissler et al. @JosephFauver @cdefilippomack @NathanGrubaugh @yhgrad @TempusLabs @NEJM https://t.co/EiRsXXqvG4 19,941 #2019nCoV samples, n=173 @NBA @TheNBPA b/w 11/28/20-8/11/21
-
-
Mashup Score: 5
T cell immunity is central for the control of viral infections. CoVac-1 is a peptide-based vaccine candidate, composed of SARS-CoV-2 T cell epitopes derived from various viral proteins1,2, combined with the Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG, aiming to induce profound SARS-CoV-2 T cell immunity to combat COVID-19. We conducted a phase I open-label trial,…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity {accelerated article preview} [Nov 23, 2021] Heitmann et al. @Nature https://t.co/CbNXfSyYvh #2019nCoV #COVDI19Vaccine HT @Ecquis
-
-
Mashup Score: 1
T cell immunity is central for the control of viral infections. CoVac-1 is a peptide-based vaccine candidate, composed of SARS-CoV-2 T cell epitopes derived from various viral proteins1,2, combined with the Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG, aiming to induce profound SARS-CoV-2 T cell immunity to combat COVID-19. We conducted a phase I open-label trial,…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity [Nov 23, 2021] Heitmann et al. @Nature https://t.co/CbNXfSyYvh #2019nCoV #COVDI19Vaccine HT @Ecquis ... ongoing evaluation in a phase II trial for patients with B cell/antibody deficiency https://t.co/xqBgvqwYRS
-
-
Mashup Score: 1The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity - 2 year(s) ago
This Medical News article discusses why experts recommend against patients getting antibody testing to assess their protection from SARS-CoV-2 after vaccination or infection.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity [Oct 21, 2021] Jennifer Abbasi @JAMANetwork https://t.co/VtEKQSf986 #2019nCoV #COVID19 #COVID19Vaccine #Testing
-
Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy [Nov 20, 2020] London et al. J Clin Immunol https://t.co/XZboOedeDs #2019nCoV #COVID19 HT @DrMJoyner